P61 NOVEL APPLICATION OF PQCT TO STANDARDISE SYNOVIAL FLUID BIOMARKER CONCENTRATIONS
Weaver Re, Jayesh Dudhia, Erc Draper, RKW Smith, A.E. Goodship
Abstract
Weaver Re, Jayesh Dudhia, Erc Draper, RKW Smith, A.E. Goodship
Abstract
Objective: To challenge the validity of using biomarker concentrations in synovial fluid for the assessment of joint pathology. Hypothesis: Synovial fluid biomarker concentrations are influenced by both cartilage and synovial fluid volumes. Methods: Synovial fluid volumes were determined from the equine metacarpophalangeal (MCP), proximal inter-phalangeal (PIP) and distal interphalangeal (DIP) joints, which have different disease prevalences. Chondrocyte density was calculated from a defined site in each joint. Cartilage volume was measured by novel application of Peripheral Quantitative Computed Tomography (pQCT). Cartilage oligomeric matrix protein (COMP), glycos-aminoglycans (GAG) and total protein (TP) concentrations were measured and then adjusted for cartilage and synovial fluid volume and compared between joints. Results: Mean synovial fluid volume was significantly greater in the MCP than the distal joints (p The DIP had higher TP, COMP and GAG concentrations, however, when values were expressed per unit cartilage volume the opposite was found, with the MCP then exhibiting significantly higher concentrations. Conclusions: These data show the joint with the highest prevalence to osteoarthritis has the lowest biomarker synovial fluid concentrations but the highest biomarker levels per unit cartilage, suggesting a higher release. These results indicate that meaningful interpretation of biomarkers in synovial fluid require consideration of both fluid and cartilage volume.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To challenge the validity of using biomarker concentrations in synovial fluid for the assessment of joint pathology. Hypothesis: Synovial fluid biomarker concentrations are influenced by both cartilage and synovial fluid volumes. Methods: Synovial fluid volumes were determined from the equine metacarpophalangeal (MCP), proximal inter-phalangeal (PIP) and distal interphalangeal (DIP) joints, which have different disease prevalences. Chondrocyte density was calculated from a defined site in each joint. Cartilage volume was measured by novel application of Peripheral Quantitative Computed Tomography (pQCT). Cartilage oligomeric matrix protein (COMP), glycos-aminoglycans (GAG) and total protein (TP) concentrations were measured and then adjusted for cartilage and synovial fluid volume and compared between joints. Results: Mean synovial fluid volume was significantly greater in the MCP than the distal joints (p The DIP had higher TP, COMP and GAG concentrations, however, when values were expressed per unit cartilage volume the opposite was found, with the MCP then exhibiting significantly higher concentrations. Conclusions: These data show the joint with the highest prevalence to osteoarthritis has the lowest biomarker synovial fluid concentrations but the highest biomarker levels per unit cartilage, suggesting a higher release. These results indicate that meaningful interpretation of biomarkers in synovial fluid require consideration of both fluid and cartilage volume.
Key concepts: Synovial fluid, Osteoarthritis, Cartilage, Biomarker, Cartilage oligomeric matrix protein, Chondrocyte, Medicine, Chemistry